"Chromosome Deletion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Actual loss of portion of a chromosome.
| Descriptor ID |
D002872
|
| MeSH Number(s) |
C23.550.210.050.500.500 G05.365.590.029.530.175 G05.365.590.175.050.500.500 G05.365.590.762.180 G05.558.800.180 G05.700.131.500.500
|
| Concept/Terms |
Partial Monosomy- Partial Monosomy
- Monosomies, Partial
- Partial Monosomies
- Monosomy, Partial
|
Below are MeSH descriptors whose meaning is more general than "Chromosome Deletion".
Below are MeSH descriptors whose meaning is more specific than "Chromosome Deletion".
This graph shows the total number of publications written about "Chromosome Deletion" by people in this website by year, and whether "Chromosome Deletion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 9 | 5 | 14 |
| 1995 | 12 | 6 | 18 |
| 1996 | 4 | 3 | 7 |
| 1997 | 15 | 2 | 17 |
| 1998 | 8 | 7 | 15 |
| 1999 | 7 | 4 | 11 |
| 2000 | 9 | 5 | 14 |
| 2001 | 7 | 5 | 12 |
| 2002 | 5 | 6 | 11 |
| 2003 | 8 | 6 | 14 |
| 2004 | 7 | 5 | 12 |
| 2005 | 9 | 6 | 15 |
| 2006 | 4 | 4 | 8 |
| 2007 | 12 | 5 | 17 |
| 2008 | 13 | 5 | 18 |
| 2009 | 19 | 9 | 28 |
| 2010 | 16 | 10 | 26 |
| 2011 | 11 | 16 | 27 |
| 2012 | 13 | 12 | 25 |
| 2013 | 11 | 6 | 17 |
| 2014 | 7 | 7 | 14 |
| 2015 | 10 | 12 | 22 |
| 2016 | 8 | 12 | 20 |
| 2017 | 6 | 4 | 10 |
| 2018 | 5 | 8 | 13 |
| 2019 | 2 | 6 | 8 |
| 2020 | 4 | 5 | 9 |
| 2021 | 3 | 8 | 11 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chromosome Deletion" by people in Profiles.
-
Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion. Blood. 2024 10 17; 144(16):1722-1731.
-
Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome. Am J Hum Genet. 2024 Aug 08; 111(8):1605-1625.
-
Reverse Phase Proteomic Array Profiling of Asparagine Synthetase Expression in Newly Diagnosed Acute Myeloid Leukemia. J Proteome Res. 2024 Jul 05; 23(7):2495-2504.
-
Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals. J Med Genet. 2024 May 21; 61(6):578-585.
-
Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome. J Neurodev Disord. 2024 May 10; 16(1):25.
-
Risk of meningomyelocele mediated by the common 22q11.2 deletion. Science. 2024 05 03; 384(6695):584-590.
-
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia. Blood Adv. 2024 04 23; 8(8):1992-2004.
-
Clinical exome sequencing efficacy and phenotypic expansions involving anomalous pulmonary venous return. Eur J Hum Genet. 2023 12; 31(12):1430-1439.
-
Updated consensus guidelines on the management of Phelan-McDermid syndrome. Am J Med Genet A. 2023 08; 191(8):2015-2044.
-
Clinical characteristics and overall survival among acute myeloid leukemia patients with TP53 gene mutation or chromosome 17p deletion. Am J Hematol. 2023 08; 98(8):1176-1184.